Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion

Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion
复制标题

DOI:
10.1038/s41590-022-01255-6
复制
发表时间:
2022-07-06
期刊:
影响因子:
30.5
通讯作者:
Sun, Bing
Sun, Bing
中科院分区:
医学1区
文献类型:
--
作者:
Chen, Wen;Chen, Shuangfeng;Sun, Bing

文献摘要

被引文献

相似文献

Sun等报道白细胞介素-33(IL-33)的分泌依赖于gasdermin D的p40 N端片段,其产生不依赖于炎症性caspase-1和caspase-11。然而,过敏原暴露后IL-33分泌的分子机制尚不清楚。在这里,我们发现两个细胞事件是暴露于过敏原后IL-33分泌的基础。首先,过敏原激活的应激颗粒组装许可IL-33的核质转运,但不是IL-33的分泌。第二,新形式的鼠氨基末端p40片段gasdermin D(Gsdmd),其产生是独立的炎症半胱天冬酶-1和半胱天冬酶-11,占主导地位的细胞溶质分泌IL-33通过在细胞膜中形成孔。阻断应激颗粒的组装或通过氨基酸残基309-313的突变(ELRQQ)消除p40的产生可以有效地阻止小鼠上皮细胞中IL-33的释放。我们的研究结果表明,靶向应激颗粒分解和Gsdmd片段化可以减少IL-33依赖性过敏性气道炎症。
Sun and colleagues describe that the secretion of interleukin-33 is dependent on a p40 N-terminal fragment of gasdermin D, whose generation is independent of inflammatory caspase-1 and caspase-11.Interleukin-33 (IL-33), an epithelial cell-derived cytokine that responds rapidly to environmental insult, has a critical role in initiating airway inflammatory diseases. However, the molecular mechanism underlying IL-33 secretion following allergen exposure is not clear. Here, we found that two cell events were fundamental for IL-33 secretion after exposure to allergens. First, stress granule assembly activated by allergens licensed the nuclear-cytoplasmic transport of IL-33, but not the secretion of IL-33. Second, a neo-form murine amino-terminal p40 fragment gasdermin D (Gsdmd), whose generation was independent of inflammatory caspase-1 and caspase-11, dominated cytosolic secretion of IL-33 by forming pores in the cell membrane. Either the blockade of stress granule assembly or the abolishment of p40 production through amino acid mutation of residues 309-313 (ELRQQ) could efficiently prevent the release of IL-33 in murine epithelial cells. Our findings indicated that targeting stress granule disassembly and Gsdmd fragmentation could reduce IL-33-dependent allergic airway inflammation.